These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6051990)

  • 1. [Changes in antistreptococcal antibodies in scarlet fever].
    Hamd SS; Guasco C
    G Mal Infett Parassit; 1967 Jun; 19(6):382-6. PubMed ID: 6051990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of some antistreptococcal antibodies in scarlet fever. I. The anti-M antibodies].
    Ulivelli A; Silenzi M
    Riv Clin Pediatr; 1966 Dec; 78(6):880-9. PubMed ID: 5999600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antistreptococcal antibody fluctuations in scarlet fever].
    Hamid SS
    Minerva Med; 1967 Oct; 58(85):3635-40. PubMed ID: 6061470
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behavior of some antistreptococal antibodies in scarlet fever. II. Antistreptokinase and antistreptohyaluronidase].
    Silenzi M; Ulivelli A; Lecchini L
    Riv Clin Pediatr; 1967; 79(3):112-27. PubMed ID: 5613878
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamics of the antibody response to streptococcal antigens in spontaneous group A beta-hemolytic streptococcus infections (scarlet fever)].
    Medina F
    Prog Immunobiol Stand; 1970; 4():597-600. PubMed ID: 4991593
    [No Abstract]   [Full Text] [Related]  

  • 6. [The quantitative relationships of serum immunoglobulins G, A, and M in comparison with the serologically demonstrable antibodies during scarlet fever and whooping cough].
    Wiedermannová D; Wiedermann D
    Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 139(1):1-12. PubMed ID: 4182035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiological mechanism of rheumatic heart disease, from the bacteriological and immunological viewpoint].
    Kotani S; Hamada S
    Nihon Rinsho; 1970 Jun; 28(6):1717-36. PubMed ID: 4916047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemolytic streptococcus and its antibodies in scarlet fever].
    GALACH'IANTS OP
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Feb; 2():23-4. PubMed ID: 14375269
    [No Abstract]   [Full Text] [Related]  

  • 9. [The passive hemagglutination test for detection of antibodies to scarlet fever toxin].
    Silich VA; Fiks LI; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):57-62. PubMed ID: 4673601
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of a new polyvalent rapid test for detection of anti-streptococcal antibodies (experience in 50 cases of scarlet fever)].
    Ulivelli A; Silenzi M
    Minerva Pediatr; 1974 Sep; 26(27):1325-39. PubMed ID: 4376211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurrence of normal antibodies in humans for somatic (group) antigens of Klebsiella].
    Kaluzewski S
    Med Dosw Mikrobiol; 1969; 21(3):271-84. PubMed ID: 5355651
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of anti group A streptococcal polysaccharide antibodies in human sera by an hemagglutination technique.
    Goldstein I; Caravano R
    Proc Soc Exp Biol Med; 1967 Apr; 124(4):1209-12. PubMed ID: 6024836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recurrent attacks of scarlet fever and penicillin treatment (author's transl)].
    Kucera H; Bauer P
    Wien Klin Wochenschr; 1974 Sep; 86(16):452-6. PubMed ID: 4428771
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scarlet fever in childhood--1969].
    Ocklitz HW; Padelt H
    Zentralbl Bakteriol Orig; 1970; 214(3):428-39. PubMed ID: 5534040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of antitoxic immunity to hemolytic Streptococcus in enclosed children's institutions].
    Silich VA; Fiks LI; Dodonov VN; Severov AM; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):139-40. PubMed ID: 149480
    [No Abstract]   [Full Text] [Related]  

  • 16. [The incidence of recurrent scarlet fever].
    Gebauer H; Kotte W; Sträubler U
    Dtsch Gesundheitsw; 1970 Feb; 25(7):308-11. PubMed ID: 5509379
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of antitoxin immunity in scarlet fever].
    Fiks LI; Bliumental' KV; Silich VA; Dodonov VN; Sezonova EP
    Pediatriia; 1972 Feb; 51(2):44-8. PubMed ID: 5036295
    [No Abstract]   [Full Text] [Related]  

  • 18. [Occurrence of antigenically diverse toxin of beta hemolytic Streptococci in scarlet fever].
    ZAHRADNICKY J; SLAVIK R
    Cesk Epidemiol Mikrobiol Imunol; 1953 Aug; 2(4):264-9. PubMed ID: 13209652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-immunological aspects of scarlet fever today].
    Timofeeva GA; Ostrovskiĭ AD; Antipova LA; Eronina MF
    Pediatriia; 1984 Mar; (3):10-4. PubMed ID: 6609342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute inflammatory reaction and immunoglobulin as well as antistreptolysin (ASLO) titer response in the serum of children with recurrent scarlet fever].
    Wiedermannová D; Wiedermann D; Kadlcáková E
    Cas Lek Cesk; 1978 Mar; 117(10):302-6. PubMed ID: 657186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.